164 related articles for article (PubMed ID: 30626816)
1. Prediction of Acute Glomerular Filtration Rate Reductions Following Renin-angiotensin System Blockade in Chronic Kidney Disease: A Possible Application of Ultrasonography in Clinical Practice.
Sugiura T; Akagaki F; Yamaguchi Y; Nakamori A
Intern Med; 2019 May; 58(9):1233-1241. PubMed ID: 30626816
[TBL] [Abstract][Full Text] [Related]
2. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
Clase CM; Barzilay J; Gao P; Smyth A; Schmieder RE; Tobe S; Teo KK; Yusuf S; Mann JF
Kidney Int; 2017 Mar; 91(3):683-690. PubMed ID: 27927602
[TBL] [Abstract][Full Text] [Related]
3. Chronological renal resistive index increases related to atherosclerotic factors, and effect of renin-angiotensin system inhibitors.
Yamaguchi Y; Akagaki F; Nakamori A; Sugiura T
Clin Exp Nephrol; 2019 Apr; 23(4):513-520. PubMed ID: 30426291
[TBL] [Abstract][Full Text] [Related]
4. Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up.
Sugiura T; Wada A
Clin Exp Nephrol; 2011 Feb; 15(1):114-20. PubMed ID: 21069409
[TBL] [Abstract][Full Text] [Related]
5. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system blockade alone or combined with ET
Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
[TBL] [Abstract][Full Text] [Related]
7. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
[TBL] [Abstract][Full Text] [Related]
8. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
[TBL] [Abstract][Full Text] [Related]
9. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
[TBL] [Abstract][Full Text] [Related]
10. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
Weir MR; Lakkis JI; Jaar B; Rocco MV; Choi MJ; Kramer HJ; Ku E
Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547
[TBL] [Abstract][Full Text] [Related]
11. The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.
Wetmore JB; Tang F; Sharma A; Jones PG; Spertus JA
Am Heart J; 2015 Oct; 170(4):735-43. PubMed ID: 26386797
[TBL] [Abstract][Full Text] [Related]
12. Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease.
Shirazian S; Grant CD; Mujeeb S; Sharif S; Kumari P; Bhagat M; Mattana J
Am J Med Sci; 2015 Jun; 349(6):510-5. PubMed ID: 26030613
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database.
Kanaoka T; Wakui H; Yano Y; Nagasu H; Kanegae H; Nangaku M; Hirakawa Y; Nakagawa N; Wada J; Tsuruya K; Nakano T; Maruyama S; Wada T; Konishi M; Nagahiro T; Yamagata K; Narita I; Yanagita M; Terada Y; Araki S; Emoto M; Okada H; Isaka Y; Suzuki Y; Yokoo T; Kataoka H; Kanda E; Kashihara N; Tamura K;
Diabetes Obes Metab; 2024 Jul; 26(7):2905-2914. PubMed ID: 38719436
[TBL] [Abstract][Full Text] [Related]
14. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD.
Abraham AG; Betoko A; Fadrowski JJ; Pierce C; Furth SL; Warady BA; Muñoz A
Pediatr Nephrol; 2017 Apr; 32(4):643-649. PubMed ID: 27826732
[TBL] [Abstract][Full Text] [Related]
16. Use of renin angiotensin system inhibitors in patients with chronic kidney disease.
Adam WR; Wright JR
Intern Med J; 2016 May; 46(5):626-30. PubMed ID: 27170242
[TBL] [Abstract][Full Text] [Related]
17. Resistive index predicts renal prognosis in chronic kidney disease.
Sugiura T; Wada A
Nephrol Dial Transplant; 2009 Sep; 24(9):2780-5. PubMed ID: 19318356
[TBL] [Abstract][Full Text] [Related]
18. [Slowing chronic kidney disease progression: hopes and disappointments. Vascular repair of chronic kidney].
Boffa JJ; Chauvet S; Mihout F
Presse Med; 2011 Nov; 40(11):1065-73. PubMed ID: 21889290
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Pisoni R; Faraone R; Ruggenent P; Remuzzi G
J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
[TBL] [Abstract][Full Text] [Related]
20. Renal function can improve at any stage of chronic kidney disease.
Weis L; Metzger M; Haymann JP; Thervet E; Flamant M; Vrtovsnik F; Gauci C; Houillier P; Froissart M; Letavernier E; Stengel B; Boffa JJ;
PLoS One; 2013; 8(12):e81835. PubMed ID: 24349134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
